No Data
No Data
A-share pharmaceutical stocks are rebounding, zhejiang shengda bio-pharm hits the limit up.
On November 20th, Shengda Bio-Pharmaceuticals hit the daily limit up, Sichuan Goldstone rose by over 8%, Apichope Pharmaceutical, Haisco Pharmaceutical Group, Zhejiang Ausun Pharmaceutical rose by over 7%, Jiangsu Hengrui Pharmaceuticals rose by over 3%.
Express News | Sichuan Goldstone Pharmaceutical: Wholly-owned subsidiary obtains the registration certificate for oseltamivir phosphate capsules.
Jinshi Asia Pharmaceutical: Report for the third quarter of 2024
Sichuan Goldstone (300434.SZ): Does not involve the production of PBO materials
Goldstone Pharma (300434.SZ) stated on the investor interaction platform on September 12 that the company is not involved in the production of PBO materials and is currently conducting research and development work on vacuum coating equipment for the surface metalization treatment of PBO materials.
Jinshi Asia Pharmaceutical: 2024 Semi-Annual Report Summary
Jinshi Asia Pharmaceutical: 2024 Semi-Annual Report